Frontiers in Immunology | Vaccines and Molecular Therapeutics

Correction

Published on 21 Mar 2025

Corrigendum: Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis

in Vaccines and Molecular Therapeutics

Rita Spathis
Deeva Robles Kuriplach
Sabrina Narvesen
Matthew Eybs
Karen Huang
Steven Torres
Madison King
Elizabeth Bagley
Pia Elustondo
Michael W. Lawlor

Frontiers in Immunology

doi 10.3389/fimmu.2025.1593193

584 views

Brief Research Report

Published on 20 Mar 2025

Targeting CCRL2 enhances therapeutic outcomes in a tuberculosis mouse model

in Vaccines and Molecular Therapeutics

Tianyin Wang
Darla Quijada
Taha Ahmedna
Jennie Ruelas Castillo
Nour Sabiha Naji
J David Peske
Petros C. Karakousis
Suman Paul
Theodoros Karantanos
Styliani Karanika

Frontiers in Immunology

doi 10.3389/fimmu.2025.1501329

1,150 views

Original Research

Published on 20 Mar 2025

Evaluation of safety, immunogenicity, and efficacy of inactivated reverse-genetics-based H5N8 highly pathogenic avian influenza virus vaccine with various adjuvants via parenteral and mucosal routes in chickens

in Vaccines and Molecular Therapeutics

Kairat Tabynov
Aidana Kuanyshbek
Leila Yelchibayeva
Kuantay Zharmambet
Zauresh Zhumadilova
Gleb Fomin
Nikolai Petrovsky
Olaitan C. Shekoni
Gourapura J. Renukaradhya
Kaissar Tabynov

Frontiers in Immunology

doi 10.3389/fimmu.2025.1539492

1,599 views

Original Research

Published on 20 Mar 2025

The first WHO reference panel for Infliximab anti-drug antibodies: a step towards harmonizing therapeutic drug monitoring

in Vaccines and Molecular Therapeutics

Meenu Wadhwa
Isabelle Cludts
Eleanor Atkinson
Peter Rigsby

Frontiers in Immunology

doi 10.3389/fimmu.2025.1550655

584 views

Clinical Trial

Published on 20 Mar 2025

Safety and immunogenicity of GamEvac-Combi, a heterologous rVSV- and rAd5-vectored Ebola vaccine: a randomized controlled multicenter clinical trial in the Republic of Guinea and Russia

in Vaccines and Molecular Therapeutics

Denis Y. Logunov
Inna V. Dolzhikova
Mamadou Y. Boiro
Anna V. Kovyrshina
Alina S. Dzharullaeva
Alina S. Erokhova
Daria M. Grousova
Amir I. Tukhvatulin
Fatima M. Izhaeva
Yana V. Simakova

Frontiers in Immunology

doi 10.3389/fimmu.2025.1487039

1,011 views

Original Research

Published on 17 Mar 2025

Evaluation of dual pathogen recognition receptor agonists as adjuvants for respiratory syncytial virus - virus-like particles for pulmonary delivery

in Vaccines and Molecular Therapeutics

Ahmedali S. Mandviwala
Komal Liman
Anke L. W. Huckriede
Vidya A. Arankalle
Harshad P. Patil

Frontiers in Immunology

doi 10.3389/fimmu.2025.1561297

1,219 views

Original Research

Published on 17 Mar 2025

Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models

in Vaccines and Molecular Therapeutics

Irene González-Domínguez
Adam Abdeljawad
Tsoi Ying Lai
Marta Boza
Stephen McCroskery
Nicholas Lemus
Stefan Slamanig
Gagandeep Singh
Prajakta Warang
Temima Yellin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1524477

1,253 views

Clinical Trial

Published on 17 Mar 2025

Measles-mumps-rubella-vaccination at 6 months of age induces measles-specific T cell responses: a randomized controlled trial

in Vaccines and Molecular Therapeutics

Søren Buus
Dorthe Maria Vittrup
Jonas Damgård Schmidt
Andreas Jensen
Anette Stryhn
Lone Graff Stensballe

Frontiers in Immunology

doi 10.3389/fimmu.2025.1546253

926 views

Review

Published on 14 Mar 2025

Insect-specific virus platforms for arbovirus vaccine development

in Vaccines and Molecular Therapeutics

Roy A. Hall
Wilson Nguyen
Alexander A. Khromykh
Andreas Suhrbier

Frontiers in Immunology

doi 10.3389/fimmu.2025.1521104

1,093 views

Brief Research Report

Published on 14 Mar 2025

OligoDOMTM: a T-cell response-enhancing platform applied to cancer immunotherapy

in Vaccines and Molecular Therapeutics

Judith Del Campo
Séverine Valsesia
Elsa Nikly
Roberto Ruiu
Antonella Iacoviello
Elena Quaglino
Federica Cavallo
Dalil Hannani
Emilie Boucher
Florence Nicolas

Frontiers in Immunology

doi 10.3389/fimmu.2025.1549112

1,003 views

Review

Published on 13 Mar 2025

Harnessing immunotherapeutic molecules and diagnostic biomarkers as human-derived adjuvants for MERS-CoV vaccine development

in Vaccines and Molecular Therapeutics

Abdullah R. Alrasheed
Maaweya Awadalla
Hadeel Alnajran
Mohammed H. Alammash
Adil M. Almaqati
Ishtiaq Qadri
Bandar Alosaimi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1538301

786 views

Original Research

Published on 13 Mar 2025

Recombinant protein Ag85B-Rv2660c-MPT70 promotes quality of BCG-induced immune response against Mycobacterium tuberculosis H37Ra

in Vaccines and Molecular Therapeutics

Jiangshan Ouyang
Shaohua Guo
Zhiming Hu
Ting Cao
Jun Mou
Xinxia Gu
Chunxu Huang
Jie Liu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1430808

833 views
1 citation

Brief Research Report

Published on 12 Mar 2025

The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-reactive T cells

in Vaccines and Molecular Therapeutics

Joel Sop
Alicia Mercado
Alexis Figueroa
Tyler P. Beckey
Caroline C. Traut
Li Zhang
Kellie N. Smith
Joel N. Blankson

Frontiers in Immunology

doi 10.3389/fimmu.2025.1513175

885 views

Original Research

Published on 12 Mar 2025

BCG-derived acellular membrane vesicles elicit antimycobacterial immunity and innate immune memory

in Vaccines and Molecular Therapeutics

Takehiro Yamaguchi
Noriaki Samukawa
Sohkichi Matsumoto
Masayuki Shiota
Masaki Matsumoto
Ryoma Nakao
Satoru Hirayama
Yutaka Yoshida
Akihito Nishiyama
Yuriko Ozeki

Frontiers in Immunology

doi 10.3389/fimmu.2025.1534615

1,179 views

Review

Published on 07 Mar 2025

Computational tools and data integration to accelerate vaccine development: challenges, opportunities, and future directions

in Vaccines and Molecular Therapeutics

Lindsey N. Anderson
Charles Tapley Hoyt
Jeremy D. Zucker
Andrew D. McNaughton
Jeremy R. Teuton
Klas Karis
Natasha N. Arokium-Christian
Jackson T. Warley
Zachary R. Stromberg
Benjamin M. Gyori

Frontiers in Immunology

doi 10.3389/fimmu.2025.1502484

1,191 views

Review

Published on 07 Mar 2025

Current state of cancer immunity cycle: new strategies and challenges of using precision hydrogels to treat breast cancer

in Vaccines and Molecular Therapeutics

Yingze Zhu
Yanlin Su
Yaxin Guo
Xinyue Wang
Zhuoqi Zhang
Yige Lu
Hang Yang
Hui Pang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1535464

794 views